Home
Alnylam Pharmaceuticals ALNY spent $290K on lobbying in Q1 2024 · Medicare
Trade details
- Type
- Lobbying report
- Amount
- $290,000
- Quarter
- Q1 2024
- Client
- Alnylam Pharmaceuticals
- Reported
- 24/04/22
Up 31.8% from last quarter
What else happened in Alnylam Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 24/03/01~24/04/30Alnylam Pharmaceuticals's other lobbying reports
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$450K
$450K
Reported 07/20
for Q2
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$60K
$60K
Reported 07/20
for Q2
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$60K
$60K
Reported 07/20
for Q2
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$60K
$60K
Reported 07/19
for Q2
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$30K
$30K
Reported 07/16
for Q2